Cue Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.00 | -$0.02 | -$0.28 |
| Q2 2024 | 1 | -$0.99 | -$0.02 | -$0.28 |
| Q3 2024 | 1 | -$0.64 | -$0.01 | -$0.18 |
| Q4 2024 | 3 | -$0.21 | $0.02 | -$0.11 |
| Q1 2025 | 2 | -$0.17 | -$0.13 | -$0.15 |
| Q2 2025 | 1 | -$0.47 | -$0.01 | -$0.13 |
| Q3 2025 | 1 | -$0.47 | -$0.01 | -$0.13 |
| Q4 2025 | 1 | -$0.48 | -$0.01 | -$0.14 |
Cue Biopharma, Inc. Earnings Date And Information
Cue Biopharma, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.2 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.09. The company had revenue of 3.34 M for the quarter and had revenue of 5.49 M for the year. Cue Biopharma, Inc. has generated $-1 earnings per share over the last year ($-1.11 diluted earnings per share) and currently has a price-to-earnings ratio of -1.17. Cue Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Cue Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.17 | $1.52 M | $3.34 M | ||
| 08/14/2024 | Q2 2024 | -$0.29 | -$0.20 | 0.09 | $1.29 M | $2.66 M |
| 05/09/2024 | Q1 2024 | -$0.30 | -$0.25 | 0.05 | $1.72 M | |
| 12/29/2023 | Q4 2023 | -$0.28 | $1.82 M | |||
| 11/03/2023 | Q3 2023 | -$0.24 | $1.31 M | $2.10 M | ||
| 08/08/2023 | Q2 2023 | -$0.30 | -$0.29 | 0.01 | $907,500 | $1.38 M |
| 05/09/2023 | Q1 2023 | -$0.33 | -$0.30 | 0.03 | $187,000 | |
| 03/21/2023 | Q4 2022 | -$0.32 | -$0.37 | -0.05 | $151,227 | |
| 11/14/2022 | Q3 2022 | -$0.38 | -$0.31 | 0.07 | $513,499 | $68,000 |
| 08/04/2022 | Q2 2022 | -$0.42 | -$0.38 | 0.04 | $1.13 M | $26,000 |
| 05/10/2022 | Q1 2022 | -$0.43 | -$0.44 | -0.01 | $1.00 M | |
| 03/16/2022 | Q4 2021 | -$0.27 | $8.25 M | |||
| 11/09/2021 | Q3 2021 | -$0.39 | -$0.41 | -0.02 | $2.40 M | $2.40 M |
| 08/09/2021 | Q2 2021 | -$0.42 | -$0.33 | 0.09 | $1.06 M | $2.74 M |
| 05/10/2021 | Q1 2021 | -$0.41 | $1.55 M | |||
| 03/09/2021 | Q4 2020 | -$0.37 | $475,325 | |||
| 11/09/2020 | Q3 2020 | -$0.34 | $1.27 M | $704,000 | ||
| 08/07/2020 | Q2 2020 | -$0.41 | -$0.38 | 0.03 | $930,000 | $1.08 M |
| 05/07/2020 | Q1 2020 | -$0.32 | -$0.48 | -0.16 | $900,000 | |
| 03/11/2020 | Q4 2019 | -$0.37 | $1.05 M |
Cue Biopharma, Inc. Earnings: Frequently Asked Questions
-
When is Cue Biopharma, Inc.'s earnings date?
Cue Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
-
Did Cue Biopharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cue Biopharma, Inc. (:CUE) reported $-0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.09.
-
How can I listen to Cue Biopharma, Inc.'s earnings conference call?
The conference call for Cue Biopharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Cue Biopharma, Inc.'s conference call transcript?
The conference call transcript for Cue Biopharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Cue Biopharma, Inc. generate each year?
Cue Biopharma, Inc. (:CUE) has a recorded annual revenue of $5.49 M.
-
How much profit does Cue Biopharma, Inc. generate each year?
Cue Biopharma, Inc. (:CUE) has a recorded net income of $5.49 M. Cue Biopharma, Inc. has generated $-1.11 earnings per share over the last four quarters.
-
What is Cue Biopharma, Inc.'s price-to-earnings ratio?
Cue Biopharma, Inc. (:CUE) has a price-to-earnings ratio of -1.17 and price/earnings-to-growth ratio is -0.16.
